MRC1 and carcinoma: In one study, there were significant organ differences in the proportion MMR protein-expression deficiency coinciding with MSI-H; the proportions were as follows: 94%, colorectal cancer; 71%–87%, endometrioid carcinoma; and 38%–40%, epithelial carcinoma of the upper urinary tract (22).